Vaccine Vendors' Greed Gone Viral
Outlook|April 17, 2017

Immunisation is a nexus controlled by big private vaccine makers, mostly foreign, that decides your baby gets 15 shots more for the doctor to make money. Even if the vaccine is useless—not to talk of the huge mark-ups.

Arushi Bedi
Vaccine Vendors' Greed Gone Viral

THERE is no vaccine against the venal mind. No immunisation ever invented gives us a complete coat of armour. The law is only good enough to catch the more obvious type of visible corruption. When it’s raised to a more abstract and institutionalised level, where it forms the very operating logic of a system that surrounds you with good words, it simply becomes the natural order of things. But once in a while, a crack develops in the consensus and the light filters through. The evening of January 20, when the lonely dissenting voice of Dr Vipin Vashishtha was sought to be banished by the Indian Academy of Paediatrics (IAP), was one such moment. What showed through in that light was the entire unholy architecture of India’s immunisation programme.

The evening did not go well for Dr Vashishtha (see interview on p 38), ex-convenor of the academy. In the late hours, his fellow members had him thrown out unceremoniously from the IAP general body meeting. The reason: Dr Vashishtha had blown the whistle on the silent collusion of interests between paediatricians and vaccine manufacturing companies. It’s a nexus that enables these companies—Indian and multinational—to push expensive vaccines into the market, some of them not even answering to a real need. The market is worth thousands of crores, and booming. And doctors make unwarranted profits in the process, at the cost of the unknowing public.

この記事は Outlook の April 17, 2017 版に掲載されています。

7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。

この記事は Outlook の April 17, 2017 版に掲載されています。

7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。

OUTLOOKのその他の記事すべて表示
Layers Of Lear
Outlook

Layers Of Lear

Director Rajat Kapoor and actor Vinay Pathak's ode to Shakespeare is an experience to behold

time-read
4 分  |
December 21, 2024
Loss and Longing
Outlook

Loss and Longing

Memories can be painful, but they also make life more meaningful

time-read
6 分  |
December 21, 2024
Suprabhatham Sub Judice
Outlook

Suprabhatham Sub Judice

M.S. Subbulakshmi decided the fate of her memorials a long time ago

time-read
8 分  |
December 21, 2024
Fortress of Desire
Outlook

Fortress of Desire

A performance titled 'A Streetcart Named Desire', featuring Indian and international artists and performers, explored different desires through an unusual act on a full moon night at the Gwalior Fort

time-read
7 分  |
December 21, 2024
Of Hope and Hopelessness
Outlook

Of Hope and Hopelessness

The body appears as light in Payal Kapadia's film

time-read
3 分  |
December 21, 2024
Ruptured Lives
Outlook

Ruptured Lives

A visit to Bangladesh in 2010 shaped the author's novel, a sensitively sketched tale of migrants' struggles

time-read
5 分  |
December 21, 2024
The Big Book
Outlook

The Big Book

The Big Book of Odia Literature is a groundbreaking work that provides readers with a comprehensive introduction to the rich and varied literary traditions of Odisha

time-read
4 分  |
December 21, 2024
How to Refuse the Generous Thief
Outlook

How to Refuse the Generous Thief

The poet uses all the available arsenal in English to write the most anti-colonial poetry

time-read
4 分  |
December 21, 2024
The Freedom Compartment
Outlook

The Freedom Compartment

#traindiaries is a photo journal shot in the ladies coaches of Mumbai locals. It explores how women engage and familiarise themselves with spaces by building relationships with complete strangers

time-read
1 min  |
December 21, 2024
Love, Up in the Clouds
Outlook

Love, Up in the Clouds

Manikbabur Megh is an unusual love story about a man falling for a cloud. Amborish Roychoudhury discusses the process of Manikbabu's creation with actor Chandan Sen and director Abhinandan Banerjee

time-read
5 分  |
December 21, 2024